Millions of fentanyl patches recalled

It's a new blow for the controversial painkiller fentanyl. Johnson & Johnson and Sandoz are recalling defective fentanyl patches that could cause patients or caregivers to overdose. The recall follows a December FDA warning that misuse can cause overdose, and another in July 2005 that instructed patients to follow package instructions strictly to avoid overdosing.

Some of the patches may have a cut in the drug reservoir that could leak potent opioid gel. Exposure to it can lead to respiratory depression and overdose, J&J said in a statement. About 32 million of the patches will be recalled. The FDA says it's investigating.

- see J&J's release about the recall
- read the AP report
- check out more from The Wall Street Journal

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.